Showing results (931-940 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|December 14, 2022
Acute GVHD: New approaches to clinical trial monitoringNikolaos Spyrou, John E Levine, James L M FerraraBest Practice & Research. Clinical Haematology|December 14, 2022
When will chemotherapy be replaced in upfront induction therapy for adult acute lymphoblastic leukemia (ALL)?Anjali AdvaniBest Practice & Research. Clinical Haematology|December 14, 2022
How can we improve response assessments in MDS? Strategies to improve response assessment in MDS treatment paradigmsRafael BejarBest Practice & Research. Clinical Haematology|December 14, 2022
Improving clinical trials in higher-risk myelodysplastic syndromesMikkael A SekeresBest Practice & Research. Clinical Haematology|December 14, 2022
Measurable residual disease in acute lymphoblastic leukemia: How low is low enough?Aaron C LoganBest Practice & Research. Clinical Haematology|November 1, 2003
The prognostic significance of antigen expression in leukaemiaRichard Schabath, Richard Ratei, Wolf Dieter LudwigBest Practice & Research. Clinical Haematology|June 19, 2018
Off the shelf T cell therapies for hematologic malignanciesBruce J McCreedy, Vladimir V Senyukov, Kim T NguyenBest Practice & Research. Clinical Haematology|October 20, 2001
Overview. Cytogenetic analysis in haematologyB J BainBest Practice & Research. Clinical Haematology|October 20, 2001
Myeloproliferative disordersA J Bench, N C Cross, B J Huntly, et al.Best Practice & Research. Clinical Haematology|October 20, 2001
Cytogenetics of chronic myeloid leukaemiaA Chase, B J Huntly, N C CrossPageof 113